DPBRN Prevalence of Questionable Occlusal Caries Lesions
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study was to investigate the process involved when making decisions about the diagnosis and treatment of questionable lesions, as well as determine if there is any association between lesions progression (or depth, if opened) and clinical characteristics and baseline risk assessment.
| Condition |
|---|
|
Dental Caries |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Prevalence of Questionable Occlusal Caries Lesions |
| Estimated Enrollment: | 2624 |
| Study Start Date: | August 2008 |
| Study Completion Date: | March 2010 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Questionable occlusal lesions |
Detailed Description:
The term"questionable" is defined as a tooth with no cavitation (no continuity break in the enamel) and no radiographic radiolucencies, but the presence of caries is suspected due to roughness, surface opacities, or staining. The characteristics of these lesions and the patient's baseline caries risk were examined.
There have been very few studies regarding questionable lesions, virtually no clinical evaluations of the progression of questionable lesions over time, and no studies depicting the prevalence of these lesions. Since carious lesions have the ability to arrest and possibly reverse, determining how often these lesions are being seen in practice and learning more about their characteristics and patient risk assessment are important steps in order to manage these lesions without unnecessary surgical intervention.
Eligibility| Ages Eligible for Study: | 6 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
The participants directly involved in this study were the patients who have sought dental treatment in the DPBRN practitioner-investigators' practices.
Inclusion Criteria:
- patients needed to have at least one permanent tooth with a questionable lesion. This means that subjects were at least 6 years old because that is when the permanent first molar typically erupts.
Exclusion Criteria:
- patients under 6 years old
- patients 6 years old and older who do not have a questionable lesion
Contacts and Locations| United States, Alabama | |
| University of Alabama at Birmingham | |
| Birmingham, Alabama, United States, 35294 | |
| United States, Florida | |
| University of Florida College of Dentistry | |
| Gainesville, Florida, United States, 32610 | |
| United States, Minnesota | |
| Health Partners Dental Group | |
| Minneapolis, Minnesota, United States, 55440-1309 | |
| Health Partners Research Foundation | |
| Minneapolis, Minnesota, United States, 55440-1524 | |
| United States, Oregon | |
| Kaiser Permanente Center for Health Research | |
| Portland, Oregon, United States, 97227 | |
| Permanente Denrtal Associates | |
| Portland, Oregon, United States, 97232 | |
| Denmark | |
| University of Copenhagen Royal Dental College | |
| Copenhagen, Denmark | |
| Principal Investigator: | Sonia K Makhija, DDS, MPH | University of Alabama at Birmingham |
More Information
Additional Information:
No publications provided
| Responsible Party: | Gregg H. Gilbert, DDS MBA, Study Chair, University of Alabama at Birmingahm |
| ClinicalTrials.gov Identifier: | NCT01201447 History of Changes |
| Other Study ID Numbers: | 119275, U01DE016747 |
| Study First Received: | September 13, 2010 |
| Last Updated: | March 3, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Dental Practice-Based Research Network:
|
Assessment Questionable Caries |
Additional relevant MeSH terms:
|
Dental Caries Tooth Demineralization Tooth Diseases Stomatognathic Diseases Salicylic Acid Anti-Infective Agents |
Therapeutic Uses Pharmacologic Actions Antifungal Agents Keratolytic Agents Dermatologic Agents |
ClinicalTrials.gov processed this record on May 23, 2013